Literature DB >> 31411076

LC-MS-based metabolomics analysis to identify meprin-β-associated changes in kidney tissue from mice with STZ-induced type 1 diabetes and diabetic kidney injury.

Jessica Gooding1, Lei Cao2, Faihaa Ahmed2, Jean-Marie Mwiza2, Mizpha Fernander2, Courtney Whitaker1, Zach Acuff1, Susan McRitchie1,3, Susan Sumner1,3, Elimelda Moige Ongeri2.   

Abstract

Meprin metalloproteases have been implicated in the pathophysiology of diabetic kidney disease (DKD). Single-nucleotide polymorphisms in the meprin-β gene have been associated with DKD in Pima Indians, a Native American ethnic group with an extremely high prevalence of DKD. In African American men with diabetes, urinary meprin excretion positively correlated with the severity of kidney injury. In mice, meprin activity decreased at the onset of diabetic kidney injury. Several studies have identified meprin targets in the kidney. However, it is not known how proteolytic processing of the targets by meprins impacts the metabolite milieu in kidneys. In the present study, global metabolomics analysis identified differentiating metabolites in kidney tissues from wild-type and meprin-β knockout mice with streptozotocin (STZ)-induced type 1 diabetes. Kidney tissues were harvested at 8 wk post-STZ and analyzed by hydrophilic interaction liquid chromatography ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Principal component analysis identified >200 peaks associated with diabetes. Meprin expression-associated metabolites with strong variable importance of projection scores were indoxyl sulfate, N-γ-l-glutamyl-l-aspartic acid, N-methyl-4-pyridone-3-carboxamide, inosine, and cis-5-decenedioic acid. N-methyl-4-pyridone-3-carboxamide has been previously implicated in kidney injury, and its isomers, 4-PY and 2-PY, are markers of peroxisome proliferation and inflammation that correlate with creatinine clearance and glucose tolerance. Meprin deficiency-associated differentiating metabolites with high variable importance of projection scores were cortisol, hydroxymethoxyphenylcarboxylic acid-O-sulfate, and isovaleryalanine. The data suggest that meprin-β activity enhances diabetic kidney injury in part by altering the metabolite balance in kidneys, favoring high levels of uremic toxins such as indoxyl sulfate and N-methyl-pyridone-carboxamide.

Entities:  

Keywords:  diabetic kidney injury; meprin metalloproteases; meprin β; metabolites; streptozotocin

Mesh:

Substances:

Year:  2019        PMID: 31411076      PMCID: PMC6843037          DOI: 10.1152/ajprenal.00166.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  79 in total

1.  Unveiling the substrate specificity of meprin beta on the basis of the site in protein kinase A cleaved by the kinase splitting membranal proteinase.

Authors:  A Chestukhin; L Litovchick; K Muradov; M Batkin; S Shaltiel
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

2.  Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Authors:  Tomohito Gohda; Monika A Niewczas; Linda H Ficociello; William H Walker; Jan Skupien; Florencia Rosetti; Xavier Cullere; Amanda C Johnson; Gordon Crabtree; Adam M Smiles; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

3.  The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.

Authors:  Nitin Kumar; Pablo Nakagawa; Branislava Janic; Cesar A Romero; Morel E Worou; Sumit R Monu; Edward L Peterson; Jiajiu Shaw; Frederick Valeriote; Elimelda M Ongeri; Jean-Marie V Niyitegeka; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

4.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.

Authors:  Davide Bolignano; Antonio Lacquaniti; Giuseppe Coppolino; Valentina Donato; Susanna Campo; Maria Rosaria Fazio; Giacomo Nicocia; Michele Buemi
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

Review 5.  Rodent models of streptozotocin-induced diabetic nephropathy.

Authors:  Greg H Tesch; Terri J Allen
Journal:  Nephrology (Carlton)       Date:  2007-06       Impact factor: 2.506

Review 6.  N-methyl-2-pyridone-5-carboxamide: a novel uremic toxin?

Authors:  Boleslaw Rutkowski; Ewa Slominska; Marek Szolkiewicz; Ryszard T Smolenski; Cindy Striley; Przemyslaw Rutkowski; Julian Swierczynski
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

7.  Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta.

Authors:  Christian Herzog; Randy S Haun; Varsha Kaushal; Philip R Mayeux; Sudhir V Shah; Gur P Kaushal
Journal:  Biochem Biophys Res Commun       Date:  2009-01-07       Impact factor: 3.575

Review 8.  Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy.

Authors:  Juan F Navarro-González; Ana Jarque; Mercedes Muros; Carmen Mora; Javier García
Journal:  Cytokine Growth Factor Rev       Date:  2009-02-28       Impact factor: 7.638

Review 9.  N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.

Authors:  Aurélie Lenglet; Sophie Liabeuf; Sandra Bodeau; Loïc Louvet; Aurélien Mary; Agnès Boullier; Anne Sophie Lemaire-Hurtel; Alexia Jonet; Pascal Sonnet; Said Kamel; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2016-11-15       Impact factor: 4.546

10.  Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.

Authors:  Chunlan Ji; Yueming Luo; Chuan Zou; Lihua Huang; Ruimin Tian; Zhaoyu Lu
Journal:  BMC Pharmacol Toxicol       Date:  2018-09-03       Impact factor: 2.483

View more
  2 in total

1.  The Biochemical Pathways of Nicotinamide-Derived Pyridones.

Authors:  Faisal Hayat; Manoj Sonavane; Mikhail V Makarov; Samuel A J Trammell; Pamela McPherson; Natalie R Gassman; Marie E Migaud
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

2.  Meprin-β activity modulates the β-catalytic subunit of protein kinase A in ischemia-reperfusion-induced acute kidney injury.

Authors:  Faihaa Ahmed; Jean-Marie Mwiza; Mizpha Fernander; Ismaila Yahaya; Shaymaa Abousaad; Elimelda Moige Ongeri
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.